Ovulation Induction

Obstetrics and Gynecology Clinics of North America

Volumn 42, Issue 1, 2015, Pages 27-37

  Von Hofe, Johanna ^a   Bates, G Wright ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Clomiphene citrate; Gonadotropins; Letrozole; Ovulation induction; Ovulation monitoring

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; DEXAMETHASONE; GONADOTROPIN; LETROZOLE; METFORMIN; PLACEBO; PREDNISONE; CLOMIFENE; ESTROGEN; FERTILITY PROMOTING AGENT; GESTAGEN;

ANOVULATION; BIRTH RATE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; EUGONADOTROPIC HYPOGONADISM; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY; LIFESTYLE MODIFICATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; REVIEW; UNEXPLAINED INFERTILITY; WEIGHT REDUCTION; AMENORRHEA; COMPLICATION; FEMALE; INFERTILITY, FEMALE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROCEDURES; TRENDS;

AMENORRHEA; ANOVULATION; CLOMIPHENE; ESTROGENS; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPINS; HUMANS; HYPOGONADISM; INFERTILITY, FEMALE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROGESTINS;

EID: 84922572648     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2014.09.007     Document Type: Review

References (48)

1. Cunningham F.G., Williams J.W. Williams obstetrics 2010, McGraw-Hill Medical, New York, xv, 1385. 23rd edition.
2. Fritz M.A., Speroff L. Clinical gynecologic endocrinology and infertility 2011, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, x, 1439. 8th edition.
3. Practice Committee of the American Society for Reproductive Medicine Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril 2013, 100(2):341-348.
4. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008, 89(3):505-522.
5. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 2012, 27(1):14-24.
6. Guzick D.S., Sullivan M.W., Adamson G.D., et al. Efficacy of treatment for unexplained infertility. Fertil Steril 1998, 70(2):207-213.
7. Deaton J.L., Gibson M., Blackmer K.M., et al. Arandomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril 1990, 54(6):1083-1088.
8. Wu C.H., Winkel C.A. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 1989, 52(4):564-568.
9. Gorlitsky G.A., Kase N.G., Speroff L. Ovulation and pregnancy rates with clomiphene citrate. Obstet Gynecol 1978, 51(3):265-269.
10. American College of Obstetricians and Gynecologists ACOG practice bulletin. Management of infertility caused by ovulatory dysfunction. Number 34, February 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002, 77(2):177-188.
11. Lobo R.A., Granger L.R., Davajan V., et al. An extended regimen of clomiphene citrate in women unresponsive to standard therapy. Fertil Steril 1982, 37(6):762-766.
12. Imani B., Eijkemans M.J., te Velde E.R., et al. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. JClin Endocrinol Metab 1998, 83(7):2361-2365.
13. Imani B., Eijkemans M.J., te Velde E.R., et al. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. JClin Endocrinol Metab 1999, 84(5):1617-1622.
14. Dhaliwal L.K., Suri V., Gupta K.R., et al. Tamoxifen: an alternative to clomiphene in women with polycystic ovary syndrome. JHum Reprod Sci 2011, 4(2):76-79.
15. Daly D.C., Walters C.A., Soto-Albors C.E., et al. Arandomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 1984, 41(6):844-848.
16. Lobo R.A., Paul W., March C.M., et al. Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynecol 1982, 60(4):497-501.
17. Trott E.A., Plouffe L., Hansen K., et al. Ovulation induction in clomiphene-resistant anovulatory women with normal dehydroepiandrosterone sulfate levels: beneficial effects of the addition of dexamethasone during the follicular phase. Fertil Steril 1996, 66(3):484-486.
18. Parsanezhad M.E., Alborzi S., Motazedian S., et al. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial. Fertil Steril 2002, 78(5):1001-1004.
19. Keay S.D., Jenkins J.M. Adjunctive use of dexamethasome in Clomid resistant patients. Fertil Steril 2003, 80(1):230-231. [author reply: 231].
20. Kosmas I.P., Tatsioni A., Fatemi H.M., et al. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril 2007, 87(3):607-612.
21. Palatnik A., Strawn E., Szabo A., et al. What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles. Fertil Steril 2012, 97(5):1089-1094.e1-3.
22. Andersen A.G., Als-Nielsen B., Hornnes P.J., et al. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod 1995, 10(12):3202-3205.
23. Legro R.S., Barnhart H.X., Schlaff W.D., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. NEngl J Med 2007, 356(6):551-566.
24. Hwu Y.M., Lin S.Y., Huang W.Y., et al. Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2005, 90(1):39-43.
25. Sahin Y., Yirmibes U., Kelestimur F., et al. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2004, 113(2):214-220.
26. Vandermolen D.T., Ratts V.S., Evans W.S., et al. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001, 75(2):310-315.
27. Holzer H., Casper R., Tulandi T. Anew era in ovulation induction. Fertil Steril 2006, 85(2):277-284.
28. Speroff L., Fritz M.A. Clinical gynecologic endocrinology and infertility 2005, Lippincott Williams & Wilkins, Philadelphia, x, 1334. 7th edition.
29. Nahid L., Sirous K. Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol 2012, 64(3):253-258.
30. Mitwally M.F., Casper R.F. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001, 75(2):305-309.
31. Begum M.R., Ferdous J., Begum A., et al. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril 2009, 92(3):853-857.
32. Badawy A., Mosbah A., Tharwat A., et al. Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertil Steril 2009, 92(1):236-239.
33. Mitwally M.F., Casper R.F. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005, 83(1):229-231.
34. Atay V., Cam C., Muhcu M., et al. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. JInt Med Res 2006, 34(1):73-76.
35. Bayar U., Basaran M., Kiran S., et al. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertil Steril 2006, 86(5):1447-1451.
36. Badawy A., Abdel Aal I., Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 2009, 92(3):849-852.
37. Badawy A., Abdel Aal I., Abulatta M. Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial. Fertil Steril 2009, 92(3):860-863.
38. Legro R.S., Brzyski R.G., Diamond M.P., et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. NEngl J Med 2014, 371(2):119-129.
39. Lathi R.B., Milki A.A. Recombinant gonadotropins. Curr Womens Health Rep 2001, 1(2):157-163.
40. Agents stimulating gonadal function in the human. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1973, 514:1-30.
41. Chong A.P., Rafael R.W., Forte C.C. Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril 1986, 46(4):599-603.
42. Balen A.H., Braat D.D.M., West C., et al. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod 1994, 9(8):1563-1570.
43. Nugent D., Vanderkerchove P., Hughes E., et al. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2000, (4). CD000410.
44. Dodson W.C., Haney A.F. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril 1991, 55(3):457-467.
45. Practice Committee of the American Society for Reproductive Medicine Use of clomiphene citrate in women. Fertil Steril 2006, 86(5 Suppl 1):S187-S193.
46. Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility Optimizing natural fertility. Fertil Steril 2008, 90(Suppl 5):S1-S6.
47. Robinson J., Wakelin M., Ellis J. Increased pregnancy rate with use of the Clearblue Easy Fertility Monitor. Fertil Steril 2007, 2:329-334.
48. Wathen N.C., Perry L., Lilford R.J., et al. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) 1984, 288(6410):7-9.